Obesity, Visceral
17
1
2
14
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 17 trials
100.0%
+13.5% vs benchmark
12%
2 trials in Phase 3/4
21%
3 of 14 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 14 completed trials
Clinical Trials (17)
NUTritional Impact of a Hypocaloric Hyperprotein Diet Before Obesity Surgery
Study of Lipolysis of Visceral Reserve Fat Using Tecar Therapy.
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Obesity
Energy Metabolism and Acute Effects of Protein Diets in Metabolically Obese Normal Weight Individuals
Long-term Benefits of Abdominal Fat Loss in Abdominally Obese Dyslipidemic Patients (SYNERGIE Study)
Extreme Exercise and Energy Expenditure (4E) Study
Genes Variability in Obesity and Normal Body Weight Patients.
Clinical Study on the Effect of a Synbiotic on Body Fat Mass
Investigation of the Effects of Different Levels of Obesity on the Respiratory System
Impact of Liraglutide 3.0 on Body Fat Distribution
Evaluation of the Effectiveness of a Comprehensive Visceral Adiposity-Focused Anti-Obesity Program
The Association of Visceral Adiposity Index With Progression of Chronic Kidney Disease
Immunometabolic Effects of Non-drug Strategies in the Clinical Management of Obesity: Translational Study
Anthropometric And Body Composition Measurements Related To Osteoporosis In Geriatric Population
Visceral Adiposity and Diabetes: Translating Form to Function Using Imaging
Medical Supervised Duodenal-Enteral Feeding Treatment
The "Metabolically-obese Normal-weight" Phenotype and Its Reversal by Calorie Restriction